Febuksostat (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Febuksostat" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

4web.archive.org

1^st place

1^st place

3,258^th place

low place

447^th place

792^nd place

2^nd place

4^th place

4^th place

13^th place

doi.org

Love BL, Barrons R, Veverka A, Snider KM (2010). "Urate-lowering therapy for gout: focus on febuxostat". Pharmacotherapy. 30 (6): 594–608. doi:10.1592/phco.30.6.594. PMID 20500048.

fda.gov

fda.gov

"Safety Alerts for Human Medical Products - Uloric (febuxostat): Drug Safety Communication - FDA to Evaluate Increased Risk of Heart-related Death". FDA (dalam bahasa Inggris). Diarsipkan dari versi asli tanggal 2018-01-25. Diakses tanggal 21 November 2017.

accessdata.fda.gov

Uloric label Diarsipkan 2017-02-10 di Wayback Machine. Updated February, 2009.

nice.org.uk

nice.org.uk

"Febuxostat for the management of hyperuricaemia in people with gout Guidance and guidelines". www.nice.org.uk. 17 December 2008. Diarsipkan dari versi asli tanggal 28 March 2017. Diakses tanggal 28 March 2017.

guidance.nice.org.uk

Febuxostat for the management of hyperuricaemia in people with gout (TA164) Chapter 4. Consideration of the evidence Diarsipkan October 6, 2010, di Wayback Machine.

nih.gov

ncbi.nlm.nih.gov

Love BL, Barrons R, Veverka A, Snider KM (2010). "Urate-lowering therapy for gout: focus on febuxostat". Pharmacotherapy. 30 (6): 594–608. doi:10.1592/phco.30.6.594. PMID 20500048.

web.archive.org

"Febuxostat for the management of hyperuricaemia in people with gout Guidance and guidelines". www.nice.org.uk. 17 December 2008. Diarsipkan dari versi asli tanggal 28 March 2017. Diakses tanggal 28 March 2017.
Febuxostat for the management of hyperuricaemia in people with gout (TA164) Chapter 4. Consideration of the evidence Diarsipkan October 6, 2010, di Wayback Machine.
"Safety Alerts for Human Medical Products - Uloric (febuxostat): Drug Safety Communication - FDA to Evaluate Increased Risk of Heart-related Death". FDA (dalam bahasa Inggris). Diarsipkan dari versi asli tanggal 2018-01-25. Diakses tanggal 21 November 2017.
Uloric label Diarsipkan 2017-02-10 di Wayback Machine. Updated February, 2009.